Tdap vaccination coverage during pregnancy, active component service women, 2006-2014.
MSMR
; 22(5): 11-4, 2015 May.
Article
em En
| MEDLINE
| ID: mdl-25996172
ABSTRACT
Tetanus, diphtheria, and acellular pertussis (Tdap) vaccines have been licensed for use in the U.S. since 2006 and have been recommended during pregnancy since 2011. Low vaccination coverage during pregnancy among the general U.S. population has been reported. Therefore, this surveillance study was conducted to assess the percentage of service women with a live birth delivery during 2006-2014 who received a Tdap vaccination during their pregnancy. Only 1%-3% of service women during 2006-2011 received a Tdap vaccine during their pregnancy. However, coverage increased to 8% in 2012 and 54% in 2014. Although this moderate Tdap coverage among military service women is an improvement over past years, more education and attention by military physicians and pregnant service women to the benefits of Tdap vaccination are needed to bring coverage closer to 100%.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Complicações Infecciosas na Gravidez
/
Tétano
/
Coqueluche
/
Vacinas contra Difteria, Tétano e Coqueluche Acelular
/
Difteria
/
Militares
Tipo de estudo:
Screening_studies
Limite:
Adult
/
Female
/
Humans
/
Pregnancy
País/Região como assunto:
America do norte
Idioma:
En
Revista:
MSMR
Ano de publicação:
2015
Tipo de documento:
Article